Developmental/Behavioral Disorders

FDA approves non-stimulant Qelbree to treat ADHD

April 06, 2021

The US Food and Drug Administration (FDA) approves first novel non-stimulant medication to treat attention-deficit/hyperactivity disorder (ADHD) in children in a decade.

Examining ADHD disparities due to race and ethnicity

March 09, 2021

Unfortunately, disparities in health care are nothing unusual. A report examines if there are disparities in attention-deficit/hyperactivity disorder (ADHD) diagnosis and treatment due to race and ethnicity.

Are people with autism more at risk of suicidality?

January 19, 2021

A recent investigation examines if people with autism spectrum disorder may be at greater risk of both death by suicide and suicide attempts.